ClinicalTrials.Veeva

Menu

Diagnosing Variable Primary Aldosteronism.

Q

Queen Mary University of London

Status

Enrolling

Conditions

High Blood Pressure
Primary Aldosteronism

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The goal of this observational study is to see if there is a cyclical or exaggerated diurnal variation in aldosterone production in people with Primary Aldosteronism.

Full description

The main questions it aims to answer are:

  • Can we diagnose more people if we used 24 hour urine measurements?
  • In those with high amounts of aldosterone in their urine, is there a variable pattern to their aldosterone production?

Participants will have a 24 hour urine measurement. They will also have multiple blood tests throughout the day to study the variability in aldosterone secretion.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • People with clinically suspected PA but have not met criteria for diagnosis. Suspicion based on low-renin (renin activity <0.5 nmol/h/L or renin mass <5 ng/L), plasma sodium > 140mmol/L or plasma potassium < 4mmol/L.
  • Patients who have been diagnosed with PA and had previous aldosterone samples <277 pmol/L, a level which would normally not qualify for confirmatory testing.
  • Patients with aldosterone results done at different times that indicate variability in production.
  • Willing to consent and participate in the study.

Exclusion criteria

  • Inability to withdraw β-adrenoceptor antagonist therapy for 2 weeks.
  • People on end of life treatment.

Trial contacts and locations

1

Loading...

Central trial contact

Yun Ni Lee; Tumi Kaminskas

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems